NCT05671445View on ClinicalTrials.gov

The Study of CM326 in Adult Subjects With Atopic Dermatitis

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 9, 2023

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2025

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

CM326

CM326 injection

Trial Locations (1)

Unknown

RECRUITING

Peking University People's hospital, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT05671445 - The Study of CM326 in Adult Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter